Fungal Infection Testing + Diagnostics for Human Health

Since 2002, MiraVista Diagnostics has been developing and evolving our menu of diagnostic tests for fungal infections. We work with hospital labs, research university labs, government and municipal labs, physician practices, large reference labs and CROs across the country to detect, analyze and monitor a wide range of serious mycology infections that afflict their patients. This includes antigen and antibody detection tests for aspergillus, blastomyces dermatitidis, histoplasma capsulatum, coccidioides, cryptococcus and beta-D-glucan.

Accurate Test Results Lead to Better Patient Outcomes

MiraVista Diagnostics understands the critical role we play in the health care and health science continuum. Because we take that responsibility seriously, we are committed to partnering with clinicians to consistently deliver:

  • Superior clinical standards in testing accuracy and sensitivity
  • Rapid response and test results
  • Dedication to excellent client service and customer satisfaction
  • Direct access to our infectious disease experts
  • Quality assurance across our organization
  • Compliance with regulatory mandates and industry best practices
  • Continuous product and service improvement
Company News

Visit MiraVista at ASM Microbe 2018 in Atlanta

MiraVista Diagnostics is exhibiting at ASM Microbe 2018 in Atlanta on June 7-11, 2018. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections. For more information about ASM Microbe…
READ MORE →

ALERT: Memorial Day Schedule: Lab & Office CLOSED on Monday, May 28

MiraVista Diagnostics’ office and laboratory will be CLOSED for Memorial Day on Monday, May 28, 2018. Please keep our holiday schedule in mind when you are sending specimens or requesting diagnostic test results. We will re-open and operate during regular…
READ MORE →

Laboratory Sales Associate

MiraVista Diagnostics (MVD) is seeking a full time Laboratory Sales Associate. This position is responsible for building and nurturing a viable pipeline of prospects that generates profitable new revenue for the company. This includes networking and building relationships with new…
READ MORE →

MiraVista Receives $630,000 in Federal & State Research Grants

National Institutes of Health (NIH) and the State of Indiana Awarded MiraVista Diagnostics More Than $630,000 in Grant Funding to Support Fungal Disease Research to Develop a New Rapid Detection Test for Coccidioidomycosis MiraVista Diagnostics, LLC (MiraVista), a developer of…
READ MORE →

MiraVista is Participating in the 62nd Annual Cocci Study Group Meeting in Flagstaff, Arizona

MiraVista Diagnostics is participating in the 62nd Annual Cocci Study Group Meeting on April 13-14 in Flagstaff, Arizona. Representatives from the company will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections. To learn more about…
READ MORE →

Inside Indiana Business Life Sciences Features MiraVista Diagnostics

Inside Indiana Business recently featured Indianapolis headquartered MiraVista Diagnostics in its Life Sciences Indiana publication. During the interview, Dr. Lawrence Joseph Wheat shared exciting news about the company’s research initiatives and expansion plans. Read the article below or link directly to…
READ MORE →

LEARN MORE
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo